Search for the latest oncology news by tumour type
Browsing: Tumour Stream
mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma
A team of researchers at The University of Texas MD Anderson Cancer Center, USA, has…
ESMO 2023: Lung cancer treatment research enters a new era
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs…
ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape
Results from highly anticipated phase 3 clinical trials in gynaecological cancers with, among others, new…
ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds
A drug that simultaneously strikes cancer cells’ growth circuits and pipeline to the bloodstream produced…
ESMO 2023: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery…
ESMO 2023: Better use of existing drugs increases cervical cancer survival and reduces recurrence
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre,…
ESMO 2023: Cemiplimab neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma
Regeneron Pharmaceuticals, Inc. today announced the first presentation of key secondary endpoints for an investigational…
ESMO 2023: Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup…
ESMO 2023: Adding immunotherapy to chemotherapy regimen improves survival in metastatic bladder cancer patients
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy…